Hansa Biopharma Investor Presentation — July 2022

Document content

Conference Call PresentationInterim Report Q2 2022 Lund, July 19, 2022

Thispresentationmaycontaincertainforward-lookingstatementsandforecastsbasedonourcurrentexpectationsandbeliefsregardingfutureeventsandaresubjecttosignificantuncertaintiesandriskssincetheyrelatetoeventsanddependoncircumstancesthatwilloccurinthefuture.Someoftheseforward-lookingstatements,bytheirnature,couldhaveanimpactonHansaBiopharma’sbusiness,financialconditionandresultsofoperations[orthatofitsparent,affiliate,orsubsidiarycompanies].Termssuchas“anticipates”,“assumes”,“believes”,“can”,“could”,“estimates”,“expects”,“forecasts”,“intends”,“may”,“might”,“plans”,“should”,“projects”,“will”,“would”or,ineachcase,theirnegative,orothervariationsorcomparableterminologyareusedtoidentifyforward-lookingstatements.Thereareanumberoffactorsthatcouldcauseactualresultsanddevelopmentstodiffermateriallyfromthoseprojected,whetherexpresslyorimpliedly,inaforward-lookingstatementoraffecttheextenttowhichaparticularprojectionisrealized.Suchfactorsmayinclude,butarenotlimitedto,changesinimplementationofHansaBiopharma’sstrategyanditsabilitytofurthergrow;risksanduncertaintiesassociatedwiththedevelopmentand/orapprovalofHansaBiopharma’sproductcandidates;ongoingclinicaltrialsandexpectedtrialresults;theabilitytocommercializeimlifidaseifapproved;changesinlegalorregulatoryframeworks,requirements,orstandards;technologychangesandnewproductsinHansaBiopharma’spotentialmarketandindustry;theabilitytodevelopnewproductsandenhanceexistingproducts;theimpactofcompetition,changesingeneraleconomyandindustryconditionsandlegislative,regulatoryandpoliticalfactors.Thefactorssetforthabovearenotexhaustiveandadditionalfactorscouldadverselyaffectourbusinessandfinancialperformance.Weoperateinaverycompetitiveandrapidlychangingenvironment,anditisnotpossibletopredictallfactors,norcanweassesstheimpactofallfactorsonourbusinessortheextenttowhichanyfactor,orcombinationoffactors,maycauseactualresultstodiffermateriallyfromthosecontainedinanyforward-lookingstatements.Giventheserisksanduncertainties,investorsshouldnotplaceunduerelianceonforward-lookingstatementsasapredictionofactualresults.HansaBiopharmaexpresslydisclaimsanyobligationtoupdateorreviseanyforward-lookingstatementstoreflectchangesinunderlyingassumptionsorfactors,newinformation,futureeventsorotherwise,anddisclaimsanyexpressorimpliedrepresentationsorwarrantiesthatmayarisefromanyforward-lookingstatements.Youshouldnotrelyupontheseforward-lookingstatementsafterthedateofthispresentation.Forward-looking statements

Preview truncated — download the full document for the complete content.